PRESTRELSKI STEVEN (Chief Scientific Officer) reported 1 transaction at XERIS PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 11/20/2019ACC: 0000899243-19-027693
Officer· Chief Scientific Officer
Since Dec 2018
-17.50K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
17.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−17.50K
Price / share
—
Trade value
—
% of position
3.9%
11/19/2019
449.32K→431.82K
Total
Net shares
−17.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2019 | G · Gift | −17.50K | — | — | 3.9% | 449.32K | 431.82K |
| Total | −17.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported